Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 8Neoplasms 4Colorectal Neoplasms 4Breast Neoplasms 3Small Cell Lung Carcinoma 2Rectal Neoplasms 2Precancerous Conditions 2Male Urogenital Diseases 2Lung Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Vascular Diseases 1Thrombocytopenia 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphedema 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Paclitaxel 177Carboplatin 177Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × Vitamin E × Clear all
NCT00228319 2018-06-19

Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants

University of Kansas Medical Center

Phase 1/2 Completed
27 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡